Schneider MR - Search Results

1

Loss of DRO1/CCDC80 results in obesity and promotes adipocyte differentiation.

Grill JI, Neumann J, Herbst A, Ofner A, Hiltwein F, Marschall MK, Zierahn H, Wolf E, Schneider MR, Kolligs FT. Grill JI, et al. Among authors: schneider mr. Mol Cell Endocrinol. 2017 Jan 5;439:286-296. doi: 10.1016/j.mce.2016.09.014. Epub 2016 Sep 16. Mol Cell Endocrinol. 2017. PMID: 27645901

2

Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins.

Schneider MR, Lahm H, Wu M, Hoeflich A, Wolf E. Schneider MR, et al. FASEB J. 2000 Apr;14(5):629-40. doi: 10.1096/fasebj.14.5.629. FASEB J. 2000. PMID: 10744620 Review.

3

Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells.

Schneider MR, Hoeflich A, Fischer JR, Wolf E, Sordat B, Lahm H. Schneider MR, et al. Cancer Lett. 2000 Apr 3;151(1):31-8. doi: 10.1016/s0304-3835(99)00401-2. Cancer Lett. 2000. PMID: 10766420

4

Insulin-like growth factor-binding protein-5 inhibits growth and induces differentiation of mouse osteosarcoma cells.

Schneider MR, Zhou R, Hoeflich A, Krebs O, Schmidt J, Mohan S, Wolf E, Lahm H. Schneider MR, et al. Biochem Biophys Res Commun. 2001 Oct 26;288(2):435-42. doi: 10.1006/bbrc.2001.5785. Biochem Biophys Res Commun. 2001. PMID: 11606061

5

IGF-binding protein-5: flexible player in the IGF system and effector on its own.

Schneider MR, Wolf E, Hoeflich A, Lahm H. Schneider MR, et al. J Endocrinol. 2002 Mar;172(3):423-40. doi: 10.1677/joe.0.1720423. J Endocrinol. 2002. PMID: 11874691 Review.

6

Insulin-like growth factor-binding protein-4 inhibits growth of the thymus in transgenic mice.

Zhou R, Flaswinkel H, Schneider MR, Lahm H, Hoeflich A, Wanke R, Wolf E. Zhou R, et al. Among authors: schneider mr. J Mol Endocrinol. 2004 Apr;32(2):349-64. doi: 10.1677/jme.0.0320349. J Mol Endocrinol. 2004. PMID: 15072544

7

Overexpression of a dominant negative GIP receptor in transgenic mice results in disturbed postnatal pancreatic islet and beta-cell development.

Herbach N, Goeke B, Schneider M, Hermanns W, Wolf E, Wanke R. Herbach N, et al. Regul Pept. 2005 Feb 15;125(1-3):103-17. doi: 10.1016/j.regpep.2004.08.021. Regul Pept. 2005. PMID: 15582721

8

Functional consequences of IGFBP excess-lessons from transgenic mice.

Wolf E, Schneider MR, Zhou R, Fisch TM, Herbach N, Dahlhoff M, Wanke R, Hoeflich A. Wolf E, et al. Among authors: schneider mr. Pediatr Nephrol. 2005 Mar;20(3):269-78. doi: 10.1007/s00467-004-1657-z. Epub 2004 Dec 16. Pediatr Nephrol. 2005. PMID: 15602658 Review.

9

Genotyping of transgenic mice: old principles and recent developments.

Schneider MR, Wolf E. Schneider MR, et al. Anal Biochem. 2005 Sep 1;344(1):1-7. doi: 10.1016/j.ab.2005.03.035. Epub 2005 Apr 9. Anal Biochem. 2005. PMID: 16105546 Review. No abstract available.

10

Betacellulin overexpression in transgenic mice causes disproportionate growth, pulmonary hemorrhage syndrome, and complex eye pathology.

Schneider MR, Dahlhoff M, Herbach N, Renner-Mueller I, Dalke C, Puk O, Graw J, Wanke R, Wolf E. Schneider MR, et al. Endocrinology. 2005 Dec;146(12):5237-46. doi: 10.1210/en.2005-0418. Epub 2005 Sep 22. Endocrinology. 2005. PMID: 16179416

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters